Imeik Technology Development Co.,Ltd. (SHE:300896)

Market Cap	27.41B -48.2%
Revenue (ttm)	2.42B -15.9%
Net Income	1.15B -38.9%
EPS	3.80 -38.9%
Shares Out	301.43M
PE Ratio	23.93
Forward PE	19.74
Dividend	1.60 (1.74%)
Ex-Dividend Date	Apr 29, 2026

Volume	3,440,971
Open	92.13
Previous Close	90.92
Day's Range	89.80 - 92.91
52-Week Range	90.12 - 202.88
Beta	0.70
Analysts	Buy
Price Target	147.32 (+61.25%)
Earnings Date	Aug 19, 2026

About SHE:300896

Imeik Technology Development Co.,Ltd. engages in the research and development, and transformation of biomedical materials and biopharmaceutical products in China. The company offers aesthetic medicine products, such as cross-linked sodium hyaluronate gel with PLLA-b-PEG microsphere; poly facial implant thread; medical sodium hyaluronate-hydroxypropyl methylcellulose gel; sodium hyaluronate composite solution for injection; modified sodium hyaluronate gel for injection; medical PVA gel ball-sodium hyaluronate-hydroxypropyl methylcellulose gel; a...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2004
• Employees: 1,458
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300896

Financial Performance

In 2025, SHE:300896's revenue was 2.45 billion, a decrease of -18.94% compared to the previous year's 3.03 billion. Earnings were 1.29 billion, a decrease of -34.05%.

Analyst Summary

According to 13 analysts, the average rating for 300896 stock is "Buy." The 12-month stock price target is ¥147.32, which is an increase of 61.25% from the latest price.

Price Target

¥147.32

(61.25% upside)

Analyst Consensus: Buy

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jun 18, 2026

Data Sources Report a data error